BSE Sensex to rise to 21,700 by year-end: Nomura

Mon Jan 14, 2013 4:24pm IST

A traffic-sign near the stock exchange building (right) reflects the sharp increase in the stock index in Mumbai January 2, 2004. REUTERS/Punit Paranjpe/Files

A traffic-sign near the stock exchange building (right) reflects the sharp increase in the stock index in Mumbai January 2, 2004.

Credit: Reuters/Punit Paranjpe/Files

Related Topics


A statue of the Ganesh, the deity of prosperity, is carried in a taxi to a place of worship on the first day of the ten-day-long Ganesh Chaturthi festival in Mumbai August 29, 2014. REUTERS/Danish Siddiqui

Ganesh Chaturthi

During Ganesh Chaturthi idols will be taken through the streets in a procession accompanied by dancing and singing, and will be immersed in a river or the sea in accordance with Hindu faith.  Slideshow 

Reuters Market Eye - Nomura expects the Sensex to touch 21,700 by the end of 2013. The investment bank says positives include potential rate cuts, easier domestic liquidity and reform momentum.

However, Nomura warns risks include "a broken" capex cycle, weak government finances, and a poor external account.

Nomura sees downside risks to consensus forecast of 13 percent earnings growth for fiscal 2014, adding it expects at most a 10 percent growth.

The Sensex is trading at 13.8 times, or a 10 percent discount to its three-year average, Nomura adds, noting that "is about right given the market's adverse macroeconomic ecosystem and high systemic imbalances - slow growth, high twin deficits and a weak rupee".

Nomura picks ICICI Bank, ITC Ltd (ITC.NS) , Mahindra & Mahindra Ltd (MAHM.NS), Dr Reddy's Laboratories Ltd (REDY.NS), and Zee Entertainment Enterprises Ltd (ZEE.NS) as its top picks for the year.

By sector, Nomura is "overweight" on banks, consumer, media, property, pharma, IT services, oil and gas, and utilities. * Nomura is "underweight" on autos, infrastructure and construction, capital goods, metals and mining, and telecoms.

(Reporting by Manoj Dharra)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

  • Most Popular
  • Most Shared


Pharma Sector

Pharma Sector

In race for bigger margins, drug makers willing to lose the India "advantage".  Full Article 

Markets This Month

Markets This Month

Tata Motors, M&M top Sensex gainers  Full Article 

Jan Dhan Yojna

Jan Dhan Yojna

Modi: Banking for all to end "financial untouchability".  Full Article 

Tracking Monsoon

Tracking Monsoon

Monsoon forecast to be better for crops next week  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage